First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupMarinde J. G. Bond, Johanneke H.M.J.V. Vestjens, Geert Kazemier et al.|The Lancet Oncology|2023Cited by 168
Development and In Vitro Proof-of-Concept of Interstitially Targeted Zinc- Phthalocyanine Liposomes for Photodynamic TherapyMans Broekgaarden, Michal Heger, Anton I.P.M. de Kroon et al.|Current Medicinal Chemistry|2013Cited by 51
Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer GroupMarinde J. G. Bond, Rutger‐Jan Swijnenburg, Babette I Kuiper et al.|Annals of Surgical Oncology|2023Cited by 17
Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trialJ Michiel Zeeuw, Geert Kazemier, Ruby Kemna et al.|European Journal of Cancer|2025Cited by 3
ASO Visual Abstract: Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases—Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer GroupMarinde J. G. Bond, Rutger‐Jan Swijnenburg, Babette I Kuiper et al.|Annals of Surgical Oncology|2023Cited by 1